Priebe Waldemar Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$340,600.00

Insider Activity of Priebe Waldemar

Biography of Priebe Waldemar

No biography is available at this moment.

2023-03-28SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
10,000
0.551%
$1.04$10,400+64.65%
2023-03-27SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2623%
$1.09$5,450+49.54%
2023-03-24SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2485%
$1.08$5,400+45.61%
2023-03-23SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
10,000
0.5395%
$1.08$10,800+56.67%
2023-03-22SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2552%
$1.08$5,400+46.85%
2023-03-21SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2623%
$1.10$5,500+48.18%
2023-03-20SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2599%
$1.08$5,400+49.54%
2023-03-17SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2646%
$1.13$5,650+48.21%
2023-03-16SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2756%
$1.24$6,200+39.41%
2023-03-15SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.258%
$1.22$6,100+31.45%
2023-03-14SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.281%
$1.35$6,750+29.37%
2023-03-13SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2563%
$1.30$6,500+22.56%
2023-03-10SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,000
0.2707%
$1.29$6,450+32.8%
2022-12-09SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
2,798
0.1826%
$2.43$6,799-31.18%
2022-12-08SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,500
0.4209%
$2.40$13,200-18.3%
2022-12-07SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,500
0.4278%
$2.46$13,530-18.99%
2022-12-06SaleCNS Pharmaceuticals, Inc.
CNSP
10 percent owner
5,500
0.4056%
$2.47$13,585-23.51%
2017-08-16SaleMoleculin Biotech, Inc.
MBRX
10 percent owner
200,000
0.6259%
$1.70$340,600-30.57%
Total: 18
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.